Clinical trial
Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries. Randomized Controlled Clinical Trial
NCT05207943 is registered in ClinicalTrials.gov with University of Las Palmas de Gran Canaria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries. Randomized Controlled Clinical Trial
- Lead sponsor
- University of Las Palmas de Gran Canaria
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- May 25, 2021
- Completion date
- December 25, 2025
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.